InsiderTrades.com logo

ZVRA Insider Trading

Insider Ownership Percentage: 2.40%
Insider Buying (Last 12 Months): $72,885.25
Insider Selling (Last 12 Months): $1,273,867.64

Zevra Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Zevra Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Zevra Therapeutics Share Price & Price History

Current Price: $9.42
Price Change: ▲ Price Increase of +0.015 (0.16%)
As of 03/20/2026 12:34 PM ET

This chart shows the closing price history over time for ZVRA up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Zevra Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/3/2026Joshua SchaferInsiderSell10,500$9.19$96,495.0062,278View SEC Filing Icon  
2/3/2026Timothy J. SangiovanniSVPSell3,000$9.18$27,540.0029,590View SEC Filing Icon  
2/2/2026Neil F. McFarlaneCEOSell91,000$9.38$853,580.00364,350View SEC Filing Icon  
1/30/2026Adrian W QuartelInsiderSell4,533$8.83$40,026.399,723View SEC Filing Icon  
1/30/2026Joshua SchaferInsiderSell3,375$8.83$29,801.2537,444View SEC Filing Icon  
1/30/2026Timothy J. SangiovanniSVPSell1,750$8.82$15,435.0020,924View SEC Filing Icon  
10/10/2025Neil F. McFarlaneCEOSell19,500$10.82$210,990.00222,016View SEC Filing Icon  
9/12/2025Tamara A FavoritoDirectorBuy3,175$7.79$24,733.253,894View SEC Filing Icon  
8/19/2025John B. BodeDirectorBuy5,000$9.16$45,800.0045,000View SEC Filing Icon  
3/28/2025Corey Michael WattonDirectorBuy300$7.84$2,352.001,800View SEC Filing Icon  
3/19/2025John B. BodeDirectorBuy10,000$7.96$79,600.0040,000View SEC Filing Icon  
2/13/2025Joshua SchaferEVPSell10,500$7.86$82,530.0029,486View SEC Filing Icon  
2/13/2025Neil F. McFarlaneCEOSell61,273$7.86$481,605.78222,060View SEC Filing Icon  
2/13/2025R. LaDuane CliftonCFOSell11,000$7.86$86,460.0051,361View SEC Filing Icon  
2/13/2025Timothy J. SangiovanniSVPSell3,000$7.86$23,580.0016,341View SEC Filing Icon  
10/11/2024Corey Michael WattonDirectorBuy500$7.92$3,960.001,500View SEC Filing Icon  
7/17/2024R. LaDuane CliftonCFOBuy2,000$6.77$13,540.0018,469View SEC Filing Icon  
7/16/2024Thomas AndersonDirectorBuy10,000$6.81$68,100.0020,000View SEC Filing Icon  
7/12/2024John B. BodeDirectorBuy10,000$5.87$58,700.0030,000View SEC Filing Icon  
9/6/2023R. LaDuane CliftonCFOBuy1,000$4.96$4,960.0015,309View SEC Filing Icon  
9/5/2023John B. BodeDirectorBuy10,000$5.13$51,300.0020,000View SEC Filing Icon  
9/5/2023Joshua SchaferEVPBuy500$5.13$2,565.003,500View SEC Filing Icon  
6/23/2023Corey Michael WattonDirectorBuy275$5.95$1,636.251,000View SEC Filing Icon  
6/9/2023Corey Michael WattonDirectorBuy325$5.52$1,794.00725View SEC Filing Icon  
5/30/2023Corey Michael WattonDirectorBuy400$5.11$2,044.00400View SEC Filing Icon  
5/19/2023Joshua SchaferEVPBuy1,000$5.42$5,420.003,000View SEC Filing Icon  
5/18/2023John B. BodeDirectorBuy10,000$5.04$50,400.0010,000View SEC Filing Icon  
5/18/2023R. LaDuane CliftonCFOBuy2,740$4.95$13,563.0013,742View SEC Filing Icon  
3/17/2023Tamara A SeymourDirectorBuy519$4.82$2,501.58719View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Zevra Therapeutics (NASDAQ:ZVRA)

35.03% of Zevra Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ZVRA by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Zevra Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
3/5/2026Gunpowder Capital Management LLC dba Oliver Wealth Management5,891$53K0.0%N/A0.010%Search for SEC Filing on Google Icon
2/24/2026DGS Capital Management LLC14,810$0.13M0.0%N/A0.026%Search for SEC Filing on Google Icon
2/18/2026NewEdge Advisors LLC4,000$36K0.0%-82.1%0.007%Search for SEC Filing on Google Icon
2/18/2026Wellington Management Group LLP170,309$1.53M0.0%-9.1%0.303%Search for SEC Filing on Google Icon
2/18/2026Polymer Capital Management US LLC17,123$0.15M0.0%-46.0%0.030%Search for SEC Filing on Google Icon
2/18/2026Millennium Management LLC1,134,358$10.16M0.0%+9.6%2.015%Search for SEC Filing on Google Icon
2/18/2026Man Group plc92,347$0.83M0.0%+174.4%0.164%Search for SEC Filing on Google Icon
2/18/2026Engineers Gate Manager LP44,020$0.39M0.0%+23.4%0.078%Search for SEC Filing on Google Icon
2/18/2026683 Capital Management LLC905,000$8.11M0.4%-7.2%1.607%Search for SEC Filing on Google Icon
2/17/2026Schonfeld Strategic Advisors LLC13,824$0.12M0.0%N/A0.025%Search for SEC Filing on Google Icon
2/17/2026AQR Capital Management LLC181,129$1.62M0.0%+18.9%0.322%Search for SEC Filing on Google Icon
2/17/2026Trexquant Investment LP209,704$1.88M0.0%-30.8%0.372%Search for SEC Filing on Google Icon
2/17/2026Price T Rowe Associates Inc. MD32,140$0.29M0.0%+12.8%0.057%Search for SEC Filing on Google Icon
2/17/2026Adage Capital Partners GP L.L.C.275,000$2.46M0.0%-87.6%0.488%Search for SEC Filing on Google Icon
2/17/2026Royal Bank of Canada4,582$42K0.0%-52.7%0.008%Search for SEC Filing on Google Icon
2/17/2026Carret Asset Management LLC54,000$0.48M0.0%-5.3%0.096%Search for SEC Filing on Google Icon
2/16/2026Squarepoint Ops LLC317,066$2.84M0.0%+18.3%0.563%Search for SEC Filing on Google Icon
2/16/2026Verition Fund Management LLC17,704$0.16M0.0%-90.9%0.031%Search for SEC Filing on Google Icon
2/16/2026Barclays PLC100,135$0.90M0.0%-69.9%0.178%Search for SEC Filing on Google Icon
2/13/2026Arete Wealth Advisors LLC69,769$0.63M0.0%-6.1%0.124%Search for SEC Filing on Google Icon
2/13/2026Nantahala Capital Management LLC1,771,936$15.88M0.5%-10.1%3.147%Search for SEC Filing on Google Icon
2/13/2026Marshall Wace LLP669,742$6M0.0%-26.6%1.190%Search for SEC Filing on Google Icon
2/13/2026The Manufacturers Life Insurance Company 16,896$0.15M0.0%-9.5%0.030%Search for SEC Filing on Google Icon
2/13/2026Schroder Investment Management Group506,033$4.46M0.0%+22.7%0.899%Search for SEC Filing on Google Icon
2/13/2026Rafferty Asset Management LLC15,920$0.14M0.0%+34.0%0.028%Search for SEC Filing on Google Icon
2/13/2026Charles Schwab Investment Management Inc.180,618$1.62M0.0%+14.5%0.321%Search for SEC Filing on Google Icon
2/13/2026State Street Corp1,482,956$13.29M0.0%+3.9%2.634%Search for SEC Filing on Google Icon
2/13/2026Wells Fargo & Company MN66,950$0.60M0.0%+81.7%0.119%Search for SEC Filing on Google Icon
2/12/2026MetLife Investment Management LLC27,867$0.25M0.0%+10.5%0.049%Search for SEC Filing on Google Icon
2/12/2026Commonwealth Equity Services LLC14,229$0.13M0.0%-45.2%0.025%Search for SEC Filing on Google Icon
2/12/2026Dimensional Fund Advisors LP154,466$1.38M0.0%N/A0.274%Search for SEC Filing on Google Icon
2/12/2026EntryPoint Capital LLC52,871$0.47M0.2%+83.1%0.094%Search for SEC Filing on Google Icon
2/12/2026Integrated Quantitative Investments LLC56,128$0.50M0.1%N/A0.100%Search for SEC Filing on Google Icon
2/12/2026Federated Hermes Inc.23,453$0.21M0.0%+17.8%0.042%Search for SEC Filing on Google Icon
2/12/2026Nuveen LLC143,132$1.28M0.0%-6.5%0.254%Search for SEC Filing on Google Icon
2/11/2026Janney Montgomery Scott LLC202,883$1.82M0.0%+10.4%0.360%Search for SEC Filing on Google Icon
2/11/2026Deutsche Bank AG45,939$0.41M0.0%+4.4%0.082%Search for SEC Filing on Google Icon
2/11/2026Fox Run Management L.L.C.24,722$0.22M0.0%-20.3%0.044%Search for SEC Filing on Google Icon
2/11/2026JPMorgan Chase & Co.412,261$3.69M0.0%-6.1%0.732%Search for SEC Filing on Google Icon
2/11/2026Los Angeles Capital Management LLC54,454$0.49M0.0%-7.0%0.097%Search for SEC Filing on Google Icon
2/11/2026Propel Bio Management LLC63,683$0.57M0.5%-72.5%0.113%Search for SEC Filing on Google Icon
2/11/2026WINTON GROUP Ltd26,089$0.23M0.0%+114.5%0.046%Search for SEC Filing on Google Icon
2/10/2026Northwestern Mutual Wealth Management Co.15,000$0.13M0.0%N/A0.027%Search for SEC Filing on Google Icon
2/9/2026Geode Capital Management LLC1,341,681$12.03M0.0%+3.2%2.383%Search for SEC Filing on Google Icon
2/9/2026Royce & Associates LP865,822$7.76M0.1%+25.3%1.538%Search for SEC Filing on Google Icon
2/9/2026Legal & General Group Plc1,097,988$9.84M0.0%+4.2%1.950%Search for SEC Filing on Google Icon
2/9/2026Simplify Asset Management Inc.42,365$0.38M0.0%-71.2%0.075%Search for SEC Filing on Google Icon
2/9/2026Jefferies Financial Group Inc.120,000$1.08M0.0%N/A0.213%Search for SEC Filing on Google Icon
2/6/2026ProShare Advisors LLC12,669$0.11M0.0%+12.3%0.023%Search for SEC Filing on Google Icon
2/4/2026Bailard Inc.12,900$0.12M0.0%N/A0.023%Search for SEC Filing on Google Icon
1/29/2026UBS Group AG285,488$2.56M0.0%+30.9%0.507%Search for SEC Filing on Google Icon
1/29/2026Sanctuary Advisors LLC34,461$0.31M0.0%+18.0%0.061%Search for SEC Filing on Google Icon
1/28/2026Retirement Planning Co of New England Inc.662,976$5.94M2.4%+10.4%1.178%Search for SEC Filing on Google Icon
1/20/2026Stratos Wealth Partners LTD.409,000$3.67M0.0%+78.6%0.726%Search for SEC Filing on Google Icon
1/14/2026Hennion & Walsh Asset Management Inc.139,591$1.25M0.0%N/A0.248%Search for SEC Filing on Google Icon
1/9/2026SG Americas Securities LLC13,543$0.12M0.0%N/A0.024%Search for SEC Filing on Google Icon
1/1/2026JPMorgan Chase & Co.438,984$4.18M0.0%+1,458.8%0.780%Search for SEC Filing on Google Icon
12/1/2025Cantor Fitzgerald L. P.117,576$1.12M0.0%+487.9%0.209%Search for SEC Filing on Google Icon
11/17/2025NewEdge Advisors LLC22,338$0.21M0.0%+458.5%0.040%Search for SEC Filing on Google Icon
11/17/2025Caxton Associates LLP17,317$0.17M0.0%N/A0.031%Search for SEC Filing on Google Icon
11/17/2025Woodline Partners LP3,476,143$33.06M0.2%-24.7%6.175%Search for SEC Filing on Google Icon
11/17/2025PharVision Advisers LLC66,733$0.64M0.4%N/A0.119%Search for SEC Filing on Google Icon
11/17/2025XTX Topco Ltd66,381$0.63M0.0%N/A0.118%Search for SEC Filing on Google Icon
11/17/2025Verition Fund Management LLC193,509$1.84M0.0%N/A0.344%Search for SEC Filing on Google Icon
11/17/2025Polymer Capital Management US LLC31,698$0.30M0.0%+89.4%0.056%Search for SEC Filing on Google Icon
11/17/2025Quarry LP10,883$0.10M0.0%N/A0.019%Search for SEC Filing on Google Icon
11/17/2025Qube Research & Technologies Ltd306,489$2.92M0.0%+2,615.2%0.544%Search for SEC Filing on Google Icon
11/17/2025Prelude Capital Management LLC15,600$0.15M0.0%N/A0.028%Search for SEC Filing on Google Icon
11/17/2025Nantahala Capital Management LLC1,971,936$18.75M0.7%+34.0%3.503%Search for SEC Filing on Google Icon
11/17/2025Millennium Management LLC1,035,251$9.85M0.0%+63.1%1.839%Search for SEC Filing on Google Icon
11/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.24,896$0.24M0.0%-17.7%0.044%Search for SEC Filing on Google Icon
11/17/2025Integrated Wealth Concepts LLC15,081$0.14M0.0%N/A0.027%Search for SEC Filing on Google Icon
11/17/2025Kingdon Capital Management L.L.C.650,000$6.18M0.8%+44.4%1.155%Search for SEC Filing on Google Icon
11/17/2025Brevan Howard Capital Management LP130,751$1.24M0.0%N/A0.232%Search for SEC Filing on Google Icon
11/17/2025Cantor Fitzgerald L. P.117,576$1.12M0.0%+487.9%0.209%Search for SEC Filing on Google Icon
11/17/2025Bank of America Corp DE288,045$2.74M0.0%+28.7%0.512%Search for SEC Filing on Google Icon
11/17/2025Boothbay Fund Management LLC14,943$0.14M0.0%N/A0.027%Search for SEC Filing on Google Icon
11/17/2025Aquatic Capital Management LLC28,593$0.27M0.0%-11.5%0.051%Search for SEC Filing on Google Icon
11/17/2025Algert Global LLC418,550$3.98M0.1%N/A0.743%Search for SEC Filing on Google Icon
11/14/2025Raymond James Financial Inc.23,306$0.22M0.0%-13.4%0.041%Search for SEC Filing on Google Icon
11/14/2025Virtu Financial LLC62,740$0.60M0.0%N/A0.111%Search for SEC Filing on Google Icon
11/14/2025Man Group plc33,652$0.32M0.0%N/A0.060%Search for SEC Filing on Google Icon
11/14/2025Squarepoint Ops LLC268,077$2.55M0.0%N/A0.476%Search for SEC Filing on Google Icon
11/13/2025Marshall Wace LLP912,299$8.68M0.0%N/A1.620%Search for SEC Filing on Google Icon
11/13/2025UBS Group AG218,096$2.07M0.0%+41.5%0.387%Search for SEC Filing on Google Icon
11/13/2025BNP Paribas Financial Markets10,993$0.11M0.0%-74.4%0.020%Search for SEC Filing on Google Icon
11/13/2025Franklin Resources Inc.36,835$0.35M0.0%N/A0.065%Search for SEC Filing on Google Icon
11/13/2025Legal & General Group Plc1,053,399$10.02M0.0%+12.6%1.871%Search for SEC Filing on Google Icon
11/13/2025WINTON GROUP Ltd12,161$0.12M0.0%N/A0.022%Search for SEC Filing on Google Icon
11/13/2025Russell Investments Group Ltd.6,374$61K0.0%+235.7%0.011%Search for SEC Filing on Google Icon
11/13/2025DLD Asset Management LP40,000$0.38M0.0%N/A0.071%Search for SEC Filing on Google Icon
11/13/2025Schroder Investment Management Group412,547$3.94M0.0%+30.8%0.733%Search for SEC Filing on Google Icon
11/12/2025Barclays PLC332,443$3.16M0.0%+218.6%0.591%Search for SEC Filing on Google Icon
11/12/2025Royce & Associates LP691,239$6.57M0.1%N/A1.228%Search for SEC Filing on Google Icon
11/12/2025Rafferty Asset Management LLC11,879$0.11M0.0%N/A0.021%Search for SEC Filing on Google Icon
11/12/2025Quantbot Technologies LP62,646$0.60M0.0%+116.1%0.111%Search for SEC Filing on Google Icon
11/12/2025Intech Investment Management LLC20,895$0.20M0.0%-18.4%0.037%Search for SEC Filing on Google Icon
11/12/2025Fox Run Management L.L.C.31,021$0.30M0.0%+175.7%0.055%Search for SEC Filing on Google Icon
11/10/2025China Universal Asset Management Co. Ltd.9,840$94K0.0%-10.4%0.017%Search for SEC Filing on Google Icon
11/10/2025Kovack Advisors Inc.175,283$1.67M0.2%+19.4%0.311%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Zevra Therapeutics logo
Zevra Therapeutics, Inc. discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company develops its products through Ligand Activated Therapy platform. Its lead product candidate is KP1077, consisting of KP1077IH, which is under Phase 2 clinical trial for the treatment of idiopathic hypersomnia, and KP1077N, which is under Phase ½ clinical trial to treat narcolepsy. The company is also developing Celiprolol, a prodrug product candidate that is under Phase 1/2 clinical trial for the treatment of vascular Ehlers Danlos syndrome. In addition, it offers AZSTARYS, a once-daily treatment for attention deficit hyperactivity disorder in patients aged six years and older; OLPRUVA to treat urea cycle disorders; and Arimoclomol for the treatment of niemann pick disease type C, an ultra-rare neurodegenerative lysosomal storage disorder. The company has collaboration and license agreement with Commave Therapeutics SA to develop, manufacture and commercialize the company's product candidates containing SDX and d-methylphenidate; and license agreement with Acer and Relief Therapeutics, Inc. to develop and commercialize rights for OLPRUVA. The company was formerly known as KemPharm, Inc. and changed its name to Zevra Therapeutics, Inc. in February 2023. Zevra Therapeutics, Inc. was incorporated in 2006 and is headquartered in Celebration, Florida.
Read More on Zevra Therapeutics

Today's Range

Now: $9.42
Low: $9.28
High: $9.46

50 Day Range

MA: $9.03
Low: $8.36
High: $11.06

52 Week Range

Now: $9.42
Low: $6.19
High: $13.16

Volume

137,245 shs

Average Volume

1,133,003 shs

Market Capitalization

$552.75 million

P/E Ratio

7.07

Dividend Yield

N/A

Beta

0.91

Who are the company insiders with the largest holdings of Zevra Therapeutics?

Zevra Therapeutics' top insider investors include:
  1. Neil F Mcfarlane (CEO)
  2. Joshua Schafer (Insider)
  3. R Laduane Clifton (CFO)
  4. John B Bode (Director)
  5. Timothy J Sangiovanni (SVP)
  6. Joshua Schafer (EVP)
  7. Thomas Anderson (Director)
  8. Adrian W Quartel (Insider)
  9. Tamara A Favorito (Director)
  10. Corey Michael Watton (Director)
Learn More about top insider investors at Zevra Therapeutics.

Who are the major institutional investors of Zevra Therapeutics?

Zevra Therapeutics' top institutional shareholders include:
  1. Nantahala Capital Management LLC — 3.15%
  2. State Street Corp — 2.63%
  3. Geode Capital Management LLC — 2.38%
  4. Millennium Management LLC — 2.01%
  5. Caption Management LLC — 0.00%
  6. Legal & General Group Plc — 1.95%
Learn More about top institutional investors of Zevra Therapeutics stock.

Which institutional investors are selling Zevra Therapeutics stock?

Within the previous quarter, ZVRA stock was sold by these institutional investors:
  1. Adage Capital Partners GP L.L.C.
  2. Marshall Wace LLP
  3. Barclays PLC
  4. Nantahala Capital Management LLC
  5. Verition Fund Management LLC
  6. Propel Bio Management LLC
  7. Simplify Asset Management Inc.
  8. Trexquant Investment LP
In the previous year, company insiders that have sold Zevra Therapeutics company stock include:
  1. Neil F Mcfarlane (CEO)
  2. Joshua Schafer (Insider)
  3. R Laduane Clifton (CFO)
  4. John B Bode (Director)
Learn More investors selling Zevra Therapeutics stock.

Which institutional investors are buying Zevra Therapeutics stock?

During the previous quarter, ZVRA stock was bought by institutional investors including:
  1. Stratos Wealth Partners LTD.
  2. Royce & Associates LP
  3. Dimensional Fund Advisors LP
  4. Hennion & Walsh Asset Management Inc.
  5. Jefferies Financial Group Inc.
  6. Caption Management LLC
  7. Millennium Management LLC
  8. Schroder Investment Management Group
In the previous year, these company insiders have bought Zevra Therapeutics stock:
  1. Neil F Mcfarlane (CEO)
  2. Joshua Schafer (Insider)
  3. R Laduane Clifton (CFO)
  4. John B Bode (Director)
  5. Timothy J Sangiovanni (SVP)
Learn More investors buying Zevra Therapeutics stock.